Cooperative Agreement U62PS004948

This $1,861,650 Project Grant awarded by the National Institute on Minority Health and Health Disparities (NIMHD) under the Minority Health and Health Disparities Research (CFDA 93.307) program will fund a national test of a culturally tailored mobile health (mHealth) intervention for smoking cessation, mental health improvement, and HIV disease management among Black adults with HIV. The grant will support the recruitment and enrollment of 300 Black people with HIV who smoke to participate in a...

The American College of Preventive Medicine, Inc. (ACPM) was awarded a $1,028,167 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the "CDC Collaboration with Academia to Strengthen Public Health" program (CFDA 93.967). The five-year award, effective August 1, 2024, will support ACPM's efforts to enhance public health infrastructure, workforce capabilities, and data systems across the United States. Specifically, ACPM will develop and deliver...

The Commonwealth of Massachusetts Department of Public Health (MDPH) was awarded a $28,065,361 cooperative agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The five-year award, running from August 2024 to May 2029, will support MDPH's comprehensive HIV prevention, surveillance, and treatment initiatives across the state. Key strategies include: Increasing HIV testing, partner services, and...

This $855,233 Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 Minority Health and Health Disparities Research) supports a study by The General Hospital Corporation, doing business as Massachusetts General Hospital, to understand mobility patterns and their impact on HIV care outcomes among adolescents and young adults living with HIV in Tennessee. The study will use a mixed-methods approach to: 1) determine patterns of personal mobility...

The Maryland Department of Health (MDH) has been awarded a $475,000 Project Grant under the Minority HIV/AIDS Fund (MHAF) program (CFDA 93.899) by the U.S. Department of Health and Human Services. This 4-year grant, effective from September 30, 2024 to September 29, 2028, will support MDH's comprehensive healthcare initiatives targeting racial and ethnic minority communities disproportionately affected by HIV/AIDS in Maryland. The grant will fund a range of services, including HIV testing,...

This federal Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $616,742 to the New York Blood Center, Inc. to study the impact of geographic mobility on pre-exposure prophylaxis (PrEP) and HIV care outcomes among Latino gay, bisexual, and other men who have sex with men (GBMSM) in New York City over a 19-month period from September 2024 to March 2025. The key objectives of this exploratory study are...

This $404,616 federal Project Grant awarded by the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) aims to evaluate the feasibility, acceptability, and preliminary efficacy of the "CHAMPION" intervention package for increasing PrEP adherence among HIV-negative methamphetamine-using men who have sex with men (MSM). The CHAMPION intervention combines two mobile health technologies - a PrEP adherence app and virtual cognitive behavioral therapy...

The Maine Mobile Health Program (MMHP), a 501(c)(3) non-profit organization, has been awarded a $600,000 Project Grant by the Health Resources and Services Administration (HRSA) under the Community Health Centers (CFDA 93.224) federal grant program. The grant, effective September 1, 2024 through August 31, 2026, will enable MMHP to: Increase the number of patients receiving mental health services from 133 in 2023 to 200 by 2025 by bolstering provider capacity through telehealth and in-person...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,576,238.00 to the University of Miami to characterize, assess, and protocolize the implementation strategies used by community-based organizations to improve the reach of PrEP and mental health/substance use treatments to Latino men who have sex with men (LMSM). The key objectives are to: Identify successful,...

This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will fund a pilot study to evaluate the feasibility and acceptability of using mail-delivered sample collection kits to detect oral human papillomavirus (HPV) infection among a diverse group of people living with HIV (PLWH). The $164,000 award to the University of California, San Francisco will support the recruitment of 135...